Why Is AXT (AXTI) Stock Down -14.60% Today?
Key Takeaways
- AXT, Inc. shares plunged approximately 14.60% intraday on Thursday, extending a brutal multi-session selloff from the prior close of $53.42 to $45.62.
- The decline appears driven by aggressive profit-taking following a parabolic year-to-date rally that had pushed the stock up more than 200% at its peak.
- Stretched valuation metrics, including a forward price-to-earnings ratio near 185x, have made the stock vulnerable to sharp reversals.
- Insider selling activity, with the CEO and directors offloading millions of dollars in shares in recent weeks, has added to negative sentiment.
- Broader semiconductor sector weakness and pre-earnings jitters ahead of the July 30 Q2 report are compounding the selling pressure.
- Traders are now watching whether the stock can hold above key technical support levels or if the correction has further to run.
Opening Summary
Shares of AXTI, the compound semiconductor substrate manufacturer AXT, Inc., tumbled sharply in Thursday's trading session, falling approximately 14.60% to $45.62 as of mid-afternoon. The stock had closed the previous session at $53.42, marking an intraday decline of roughly $7.80 per share. The selloff represents a continuation of intense volatility that has characterized the stock in recent weeks, as the high-beta name grapples with profit-taking, valuation concerns, and uncertainty ahead of its upcoming quarterly earnings report.
Profit-Taking After a Parabolic Rally
The most immediate driver behind Thursday's plunge is the unwinding of an extraordinary rally that had made AXTI one of the standout performers in the semiconductor space this year. The stock had surged more than 200% year-to-date at its peak, fueled by investor enthusiasm around the company's indium phosphide wafer business and its exposure to artificial intelligence-driven data center demand. Such parabolic moves often invite sharp corrections as momentum traders lock in gains, and the current selloff fits that pattern. After reaching intraday highs above $115 in mid-June, the stock has now retraced more than 60% from those levels, underscoring the ferocity of the reversal.
Valuation Concerns Weigh on Sentiment
Even after the steep decline, AXTI trades at a forward price-to-earnings multiple near 185x, a level that leaves virtually no margin for error. The company reported negative trailing twelve-month earnings per share and negative net margins, meaning the stock is priced almost entirely on future growth expectations tied to AI optical networking demand. When growth narratives falter or market sentiment shifts, richly valued names like AXT are often the first to be sold. With the broader market showing signs of rotation away from high-multiple technology stocks, the valuation premium attached to AXTI has become a liability rather than an asset.
Insider Selling Adds to Downward Pressure
Recent regulatory filings have revealed significant insider selling at AXTI, which may be contributing to the negative sentiment. Chief Executive Officer Morris S. Young sold over 123,000 shares in early June at prices above $113, netting approximately $14 million. Director Jesse Chen also disclosed multiple sales in mid-June totaling more than $2.7 million, while CFO Gary L. Fischer sold nearly 90,000 shares. Over the past six months, insiders have executed 33 sales and zero purchases. While insider selling can occur for personal financial planning reasons unrelated to company prospects, the one-sided nature of the activity has not gone unnoticed by the market.
Broader Semiconductor Sector Weakness
The selloff in AXTI is not occurring in isolation. The semiconductor sector has faced headwinds in recent sessions as investors reassess valuations across the AI supply chain. While demand for indium phosphide substrates tied to optical networking and high-speed data transmission remains a compelling long-term thesis, near-term uncertainty around customer order patterns, export permit timelines in China, and the pace of AI infrastructure buildout has created a more cautious trading environment. AXT's high beta of 1.87 means it amplifies both sector rallies and sector selloffs, making it particularly vulnerable during risk-off rotations.
Pre-Earnings Uncertainty
Adding to the volatility is the approaching Q2 fiscal 2026 earnings report, scheduled for July 30. The company previously guided for earnings per share of $0.06 to $0.08, and investors are keenly focused on whether the indium phosphide backlog—reportedly above $100 million—is translating into accelerating revenue growth. The recent decision by AXT's Tongmei subsidiary to shift its planned IPO from Shanghai to Hong Kong has also introduced uncertainty around the timeline and structure of that capital-raising event. Until the earnings report provides clarity, the stock is likely to remain susceptible to sharp swings driven by shifting expectations.
Market Context and Trading Activity
Trading volume in AXTI has been elevated throughout the recent selloff, indicating that institutional investors are actively repositioning. The stock's average daily volume exceeds 10 million shares, and recent sessions have seen turnover well above that threshold. The decline has pushed the stock decisively below its 50-day simple moving average, which stood near $93, and it is now testing levels around its 200-day moving average near $59—a technical zone that, if broken, could accelerate selling pressure. The stock's 52-week range of $1.85 to $143.16 illustrates the extreme volatility that has defined trading in this name.
Trending AI Robots
In volatile market environments like the one currently affecting AXTI, traders often turn to algorithmic strategies to navigate rapid price swings. Tickeron's Trending AI Robots page features a curated selection of AI-powered trading bots that have demonstrated strong performance under current market conditions. With hundreds of bots covering thousands of tickers across various strategies, timeframes, and performance metrics, the platform highlights only those robots that are currently excelling. Traders seeking to complement their own analysis with data-driven signals may find value in exploring the Trending AI Robots section to identify strategies aligned with today's market dynamics.
What Comes Next for AXTI
The near-term trajectory for AXTI hinges heavily on the July 30 earnings release and management's commentary on indium phosphide demand, capacity expansion progress, and the Tongmei Hong Kong IPO timeline. Analysts remain divided, with price targets ranging from $21 at B. Riley Securities to $125 at Northland Securities, reflecting wide disagreement about the stock's fair value. Key risks include potential delays in Chinese export permits, execution challenges in scaling indium phosphide production to the targeted $35 million in quarterly capacity, and the possibility of further shareholder dilution if additional capital raises are needed. On the positive side, the company's multi-year supply agreements—including the recent $22.3 million prepaid deal with Coherent and the $25.4 million contract with Nanjing Casela—provide revenue visibility that could support a stabilization in the stock once the current wave of selling exhausts itself. For now, traders are watching whether the stock can establish a floor above the psychologically important $40 level or if the correction has further to run before bargain hunters step in.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
AXTI's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for AXTI turned positive on July 21, 2026. Looking at past instances where AXTI's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on AXTI as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
AXTI moved above its 50-day moving average on August 06, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AXTI crossed bullishly above the 50-day moving average on August 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where AXTI advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The 10-day RSI Indicator for AXTI moved out of overbought territory on August 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXTI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AXTI broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AXTI entered a downward trend on August 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock slightly worse than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.737) is normal, around the industry mean (9.059). AXTI's P/E Ratio (2583.333) is considerably higher than the industry average of (175.859). AXTI's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.668). Dividend Yield (0.000) settles around the average of (0.006) among similar stocks. P/S Ratio (32.051) is also within normal values, averaging (38.491).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufactures of high-performance compound semiconductor substrates
Industry ElectronicProductionEquipment
Advertisement